Scopus Biopharma, Inc. (SCPS)
| Market Cap | 102.63M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.86M |
| Shares Out | 13.36M |
| EPS (ttm) | -0.81 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 19 |
| Last Price | $7.68 |
| Previous Close | $7.54 |
| Change ($) | 0.14 |
| Change (%) | 1.86% |
| Day's Open | 7.51 |
| Day's Range | 7.52 - 7.82 |
| Day's Volume | 19,874 |
| 52-Week Range | 5.34 - 47.86 |
NEW YORK, March 15, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the finalization of arrangements for the completion of the investigational new drug ("IND") package for th...
NEW YORK, Feb. 10, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of the underwriters' over-allotment option in full, bringing total follow-on public offering proc...
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced that the underwriters of the company's follow-on public offering exercised their over-allotment option in full...
NEW YORK, Jan. 29, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the closing of a $9 million follow-on public offering. The offering consisted of 1,000,000 shares of common...
NEW YORK, Jan. 27, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced that it intends to effectuate an exchange offer (the "Exchange") pursuant to which Scopus BioPharma common ...
NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: "SCPS") today announced the pricing of a $9 million follow-on public offering. The offering consists of 1,000,000 shares of common ...
NEW YORK, Jan. 19, 2021 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the completion of clinical lot manufacturing fulfilling the requirements for the planned Phase 1 clinical tri...
NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the appointment of additional members to its Board of Directors. Scopus is a biopharmaceutical company whose ...
NEW YORK, Dec. 18, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the closing of its initial public offering. The underwriters for the initial public offering exercised their ...
Scopus BioPharma (SCPS) stock is soaring higher as the company's IPO continues on Thursday and InvestorPlace has all the details. The post SCPS Stock: 14 Things to Know About the Scopus BioPharma IPO ap...
Scopus Biopharma Inc (NASDAQ: SCPS) shares, which debuted on the Nasdaq Wednesday, are ripping higher. What Happened: New York-based Scopus, a biopharma company developing therapeutics for serious disea...
Shares of Oriental Culture Holding Ltd. more than tripled (up 204.3%) in premarket trading Thursday, as the Hong Kong-based provider of collectibles and artwork e-commerce services heads for its third s...
NEW YORK, Dec. 15, 2020 /PRNewswire/ -- Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the pricing of its initial public offering. The company's common stock is set to begin trading Wednesday, Dec...
About SCPS
Scopus Biopharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. To achieve our mission, we seek to capitalize on ground-breaking scientific and medical discoveries at some of the world’s foremost academic and research institutions. Our strategic partners, City of Hope, NIH and Hebrew University and their respective scientists, medical doctors and other senior researchers with whom we are working at each of our strategic partners are leaders in their resp... [Read more...]
| Industry Biotechnology | IPO Date Dec 16, 2020 |
| CEO Morris C. Laster, M.D. | Employees 1 |
| Stock Exchange NASDAQ | Ticker Symbol SCPS |